Catalent Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
XNCR | B | Xencor, Inc. | 0.67 | |
CTLT | D | Catalent, Inc. | 1.32 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
MNA | C | IQ Merger Arbitrage ETF | 5.63 | |
IHE | D | iShares U.S. Pharmaceutical ETF | 4.23 | |
EVNT | B | AltShares Event-Driven ETF | 3.94 | |
PBE | D | PowerShares Dynamic Biotech & Genome | 3.88 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 3.41 |
Compare ETFs
- Catalent
Catalent, Inc. (Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, including approximately 2,400 scientists and technicians. In fiscal year 2019, it generated over $2.5 billion in annual revenue.Catalent was formed in April 2007 when affiliates of the Blackstone Group L.P. acquired the core of the pharmaceutical technologies and services (PTS) segment of Cardinal Health, Inc. Cardinal Health created PTS through a series of acquisitions starting with R.P. Scherer Corporation in 1998.In 2014, Catalent became a public company and is listed on the New York Stock Exchange.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles